Adaptive changes in the rat hippocampal glutamatergic neurotransmission are observed during long-term treatment with lorazepam
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Rationale Chronic treatment with benzodiazepines induces tolerance to most of their pharmacological effects. The best-studied neurochemical correlation to this phenomenon involves GABAergic adaptive changes. However, some compensation by excitatory neurotransmission could also be postulated.Objective The aim of this work was to investigate the effect of chronic treatment with benzodiazepines on several parameters of hippocampal glutamatergic neurotransmission.Methods Rats were injected (IP) with a single dose or daily doses (21 days) of 1 mg/kg lorazepam (LZ) or vehicle. Thirty minutes after the last dose, animals were killed and parameters were measured in the dissected hippocampi. We determined one presynaptic parameter, in vitro glutamate release induced by a 60 mM K(+) stimulus. [(3)H]MK-801 binding to postsynaptic NMDA receptors and the NMDA-stimulated efflux of cGMP were also evaluated.Results While no changes were observed in any of the parameters after a single dose of the drug, we found an increase of 206% in in vitro glutamate release in chronically treated animals [two-way ANOVA: F(1,16)=6.22], together with an increment of 103% in the NMDA-stimulated cGMP efflux [two-way ANOVA: F(1,18)=14.05]. No changes either in K(D) or in B(max) values for [(3)H]MK-801 binding to hippocampal membranes were observed.Conclusions Taken together, these changes strongly suggest that a compensatory increase in the glutamatergic response develops in the hippocampus during chronic treatment with LZ. Our findings might indicate a contribution of glutamatergic mechanisms to the tolerance to hippocampal-mediated effects of LZ, such as amnesic and anticonvulsant activities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In support, after long-term (but not acute) lorazepam treatment, no differences were found in the affinity or density of NMDA receptors, even though increased in vitro glutamate release and NMDA-induced cGMP efflux in the hippocampus was reported [128].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [128]
Citations
Cites
Izquierdo, I., & Medina, J. H. (1997) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1997.3799 · Cited by 959
In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway
Fedele, E., & Raiteri, M. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00077-x · Cited by 171 · cited 4×
“Our observations on cGMP efflux support this possibility, as an increase in this parameter was observed after stimulation with NMDA which, acting at NMDA receptors, stimulates NOS/soluble guanylyl cyclase pathway ( Fedele and Raiteri 1999 ).”
BackgroundInfluentialWeiland, N. G., Orchinik, M., & Tanapat, P. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00619-7 · Cited by 128 · cited 2×
“Membranes were prepared according to the method described by Weiland et al. (1997) .”
MethodPaul, I. A., Layer, R. T., Skolnick, P., & Nowak, G. (1993) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(93)90199-j · Cited by 97
Izzo, E., Auta, J., Impagnatiello, F., Pesold, C., Guidotti, A., & Costa, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051628698 · Cited by 90 · cited 2×
“Izzo et al (2001) investigated the expression of hippocampal GluR1 and NR1 subunits of AMPA and NMDA receptors, respectively, during tolerance and after withdrawal of diazepam.”
BackgroundStability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
Kegeles, L. S., Zea-Ponce, Y., Abi-Dargham, A., Rodenhiser, J., Wang, T., Weiss, R., Van Heertum, R. L., Mann, J. J., & Laruelle, M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990315)31:4<302::aid-syn9>3.0.co;2-a · Cited by 80
Hu, X. J., & Ticku, M. K. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10146-6 · Cited by 64
Tietz, E. I., Huang, X., Chen, S., & Ferencak, W. F. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00516-8 · Cited by 63
Nowak, G., Legutko, B., Skolnick, P., & Popik, P. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01589-6 · Cited by 61
Longone, P., Impagnatiello, F., Guidotti, A., & Costa, E. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00071-8 · Cited by 48
Cited by
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
“…investigating the effect of chronic (21 days) treatment with lorazepam found that, while glutamate release from prefrontal cortex slices in superfusion was reduced, in hippocampus the same treatment resulted in a marked and significant increase of glutamate release (Bonavita et al., 2002, 2003).”
BackgroundVinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
“In support, after long-term (but not acute) lorazepam treatment, no differences were found in the affinity or density of NMDA receptors, even though increased in vitro glutamate release and NMDA-induced cGMP efflux in the hippocampus was reported [128].”
BackgroundMusazzi, L., Treccani, G., Mallei, A., & Popoli, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.009 · Cited by 172
Effects of mitragynine from Mitragyna speciosa Korth leaves on working memory
Apryani, E., Hidayat, M. T., Moklas, M. A. M., Fakurazi, S., & Idayu, N. F. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.03.036 · Cited by 80
Cheng, T., Wallace, D. M., Ponteri, B. B., & Tuli, M. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s164307 · Cited by 66
“100,101 It appears that NMDA upregulation happens acutely after benzodiazepine administration, because NMDA antagonists dizocilpine (MK-801) and CPP were able to prevent tolerance to sedative and withdrawal effects after benzodiaz-epine administration.”
Metadata
- Authors
- Bonavita, C., Ferrero, A., Cereseto, M., Velardez, M., Rubio, M., & Wikinski, S.
- Affiliations
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Universidad de Buenos Aires (AR)
- Corresponding author
- Wikinski, S.
- ORCID
- Wikinski, S.
- Venue
- Psychopharmacology
- Published
- 2003-01-24
- Volume
- 166
- Issue
- 2
- Pages
- 163-167
- ISSN
- 0033-3158 (ISSN-L)
- OpenAlex
- W2088095686
- Cited by
- 16
- References
- 25
- Citations by year
- 2023: 1 · 2022: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2012: 2
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- lorazepam, benzodiazepine tolerance, chronic drug administration, hippocampus, glutamatergic neurotransmission, glutamate release, NMDA receptor, MK-801 binding, amnesia, anticonvulsant activity
- MeSH terms
- Adaptation, Physiological, Animals, gamma-Aminobutyric Acid, Cyclic GMP, Hippocampus, Lorazepam, Male, Synaptic Transmission, Potassium, Anti-Anxiety Agents, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Dizocilpine Maleate, Rats, Wistar, Glutamic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adaptive changes in the rat hippocampal glutamatergic neurotransmission are observed during long-term treatment with lorazepam. https://app.cochat.ai/papers/10.1007/s00213-002-1373-y
- The paper
- Bonavita, C., Ferrero, A., Cereseto, M., Velardez, M., Rubio, M., & Wikinski, S. (2003). Adaptive changes in the rat hippocampal glutamatergic neurotransmission are observed during long-term treatment with lorazepam. Psychopharmacology. https://doi.org/10.1007/s00213-002-1373-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.